Despite limited evidence for outpatient pharmacotherapy in children with BPD, we identified consistent cross-center practice patterns. Providers reported that while the utilization of therapies was associated with higher BPD severity and greater respiratory support, medications were prescribed across the spectrum of disease severity. Treatment practices varied by age group and were often hindered by common barriers to accessing medications. These findings underscore the need to revise clinical guidelines to enhance long-term outpatient pharmacotherapy for infants and children with BPD.
Tracy et al. (Wed,) studied this question.